Mitigation of Platinum Depletion in Platinum Diffused Single Phase Bond Coat on CMSX-4 Superalloy

Pt-diffused bond coat with a mixture of γ/γ’ phase has just been developed in the recent decades as a cheaper alternative to the Pt-enriched β-phase Aluminide bond coat that contains a higher content of Al. However, concerns are raised on the inevitable depletion of Pt near the coating interface that may endanger the component after long-term service. In this study, modified Pt-diffused bond coats with a single phase (γ or γ’) were made by applying selective etching on CMSX-4 single crystal superalloys prior to the electroplating of Pt. The single-phase bond coats show distinctive diffusion behaviour in comparison with the conventional γ/γ’ bond coat. Surprisingly, Pt remains more stable in the γ’-phase bond coat with significantly less depletion after diffusion, which implies a potential in saving a considerable amount of Pt. On the other hand, however, the depletion of Pt is more severe in the γ-phase bond coat. The mechanism that governs the diffusion behavior of Pt in the γ and γ’-phase was also discussed that mainly concerns with thermodynamic and kinetic factors

Mitigation of Platinum Depletion in Platinum Diffused Single Phase Bond Coat on CMSX-4 Superalloy

From MDPI via Jisc Publications RouterHistory: accepted 2021-05-28, pub-electronic 2021-05-31Publication status: PublishedPt-diffused bond coat with a mixture of γ/γ’ phase has just been developed in the recent decades as a cheaper alternative to the Pt-enriched β-phase Aluminide bond coat that contains a higher content of Al. However, concerns are raised on the inevitable depletion of Pt near the coating interface that may endanger the component after long-term service. In this study, modified Pt-diffused bond coats with a single phase (γ or γ’) were made by applying selective etching on CMSX-4 single crystal superalloys prior to the electroplating of Pt. The single-phase bond coats show distinctive diffusion behaviour in comparison with the conventional γ/γ’ bond coat. Surprisingly, Pt remains more stable in the γ’-phase bond coat with significantly less depletion after diffusion, which implies a potential in saving a considerable amount of Pt. On the other hand, however, the depletion of Pt is more severe in the γ-phase bond coat. The mechanism that governs the diffusion behavior of Pt in the γ and γ’-phase was also discussed that mainly concerns with thermodynamic and kinetic factors

Photometric observations of flares on AD Leo from GWAC-F30 and TESS

We observed active M dwarf star AD Leo for 146 hr in photometry by GWAC-F30 and also analyzed 528-hr photometric data of the star from TESS. A total of 9 and 70 flares are detected from GWAC-F30 and TESS, respectively. Flare durations, amplitudes and energies are calculated. The distributions of the three properties and FFDs are given. Within the same energy range of flares, the FFDs of AD Leo obtained in this research and the previous study are basically consistent, which suggests that the magnetic activity of this star has not significantly changed compared to that decades ago. Comparing with the average FFD of M-type stars, AD Leo's FFD is twice higher, indicating that its magnetic activity is more active than that of the average level of the M-type. Based on TESS light curve, AD Leo's rotation period is calculated as 2.21${+0.01 \choose -0.01}$ day , supporting the result given in previous research. During the decay phase of the most energetic flare from TESS, we identified QPPs and determined a 26.5-min oscillation period, which is currently the longest period for AD Leo, suggesting that long periodic physical process existed during flare of this star

2-[3-((Z)-2-{4-[Bis(2-chloro­eth­yl)amino]­phen­yl}ethen­yl)-5,5-dimethyl­cyclo­hex-2-en-1-yl­idene]propane­dinitrile

The highly conjugated title compound, C23H25Cl2N3, is nearly planar (the mean deviation from the plane being 0.049 Å), except for the –C(CH3)2 group on the cyclo­hexene ring and the two CH2Cl groups. The cyclo­hexene ring has an envelope configuration. In the crystal, the packing is stabilized by C—H⋯Cl inter­actions and C—H⋯π inter­actions involving the benzene ring

TGFB-INHB/activin signaling regulates age-dependent autophagy and cardiac health through inhibition of MTORC2 Autophagy

Age-related impairment of macroautophagy/autophagy and loss of cardiac tissue homeostasis contribute significantly to cardiovascular diseases later in life. MTOR (mechanistic target of rapamycin kinase) signaling is the most well-known regulator of autophagy, cellular homeostasis, and longevity. The MTOR signaling consists of two structurally and functionally distinct multiprotein complexes, MTORC1 and MTORC2. While MTORC1 is well characterized but the role of MTORC2 in aging and autophagy remains poorly understood. Here we identified TGFB-INHB/activin signaling as a novel upstream regulator of MTORC2 to control autophagy and cardiac health during aging. Using Drosophila heart as a model system, we show that cardiac-specific knockdown of TGFB-INHB/activin-like protein daw induces autophagy and alleviates age-related heart dysfunction, including cardiac arrhythmias and bradycardia. Interestingly, the downregulation of daw activates TORC2 signaling to regulate cardiac autophagy. Activation of TORC2 alone through overexpressing its subunit protein rictor promotes autophagic flux and preserves cardiac function with aging. In contrast, activation of TORC1 does not block autophagy induction in daw knockdown flies. Lastly, either daw knockdown or rictor overexpression in fly hearts prolongs lifespan, suggesting that manipulation of these pathways in the heart has systemic effects on longevity control. Thus, our studies discover the TGFB-INHB/activin-mediated inhibition of TORC2 as a novel mechanism for age-dependent decreases in autophagic activity and cardiac health

Diagnosis and functional prediction of microbial markers in tumor tissues of sporadic colorectal cancer patients associated with the MLH1 protein phenotype

ObjectiveMost patients with sporadic colorectal cancer (SCRC) develop microsatellite instability because of defects in mismatch repair (MMR). Moreover, the gut microbiome plays a vital role in the pathogenesis of SCRC. In this study, we assessed the microbial composition and diversity of SCRC tumors with varying MutL protein homolog 1 (MLH1) status, and the effects of functional genes related to bacterial markers and clinical diagnostic prediction.MethodsThe tumor microbial diversity and composition were profiled using high-throughput sequencing of the 16S ribosomal RNA (rRNA) gene V4 region. Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt2) software and BugBase tool were used to predict the functional roles of the microbiome. We aimed to construct a high-accuracy model to detect and evaluate the area under the receiver operating characteristic curve with candidate biomarkers.ResultsThe study included 23 patients with negative/defective MLH1 (DM group) and 22 patients with positive/intact MLH1 (IM group). Estimation of alpha diversity indices showed that the Shannon index (p = 0.049) was significantly higher in the DM group than in the controls, while the Simpson index (p = 0.025) was significantly lower. At the genus level, we observed a significant difference in beta diversity in the DM group versus the IM group. Moreover, the abundance of Lachnoclostridium spp. and Coprococcus spp. was significantly more enriched in the DM group than in the IM group (q < 0.01 vs. q < 0.001). When predicting metagenomes, there were 18 Kyoto Encyclopedia of Genes and Genomes pathways and one BugBase function difference in both groups (all q < 0.05). On the basis of the model of diagnostic prediction, we built a simplified optimal model through stepwise selection, consisting of the top two bacterial candidate markers (area under the curve = 0.93).ConclusionIn conclusion, the genera Lachnoclostridium and Coprococcus as key species may be crucial biomarkers for non-invasive diagnostic prediction of DM in patients with SCRC in the future

Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China

There are limited studies on the prevalence and incidence of clinically diagnosed hypertrophic myocardiopathy (HCM) and its mortality in the Chinese population, and the projected population burden of HCM over the next decades. We collected data on HCM and its mortality from the Beijing Municipal Health Commission Information Center (BMHCIC) database and estimated the prevalence and incidence based on the whole Beijing population. Calculation of population trends was performed using annual percentage change (APC) and average annual percentage change (AAPC). Finally, future HCM incidence was built by modelling projection of HCM to the next decades using Poisson regression analysis and Gray Model 1,1(GM [1,1]). The prevalence of HCM was 0.0069% (95%CI, 0.0065–0.0072%; N = 1343) in 2010, rising to 0.076% (95% CI, 0.074–0.077%; N = 16,616) in 2019, and the incidence of HCM was 6.85 per 100 000 person-year in 2010, rising to 11.76 per 100 000 person-year in 2019. Males had higher prevalence and incidence of HCM than females. The APPC for the rising incidence of HCM was 5.8% and the expected numbers will double increase in 2029 by assuming the same increase trend as the last decades. HCM had increased annual incidence of HF (APPC: 8.4, 4.4–12.6, p  0.05) during the studied period. Males had lower mortality (2.70% vs. 4.20%, p < 0.001) than females. The calculated HCM prevalence was much lower compared to prior screening studies from 2004, although the predicted HCM incidence would double over the next decades. HCM was associated with a stable risk of mortality during the studied period

Fibrosis progression in interferon treatment-naive Chinese plasma donors with chronic hepatitis C for 20 years: a cohort study

SummaryObjectivesTo evaluate the progression of fibrosis and factors influencing this in interferon (IFN) treatment-naive Chinese plasma donors infected with hepatitis C virus (HCV) for approximately 20 years.MethodsFrom July 2010 to June 2011, we investigated 122 IFN treatment-naive chronic hepatitis C (CHC) patients infected by plasma donation in 1992–1995. Liver fibrosis stage and inflammation grade were evaluated by Metavir and Scheuer scoring systems, respectively.ResultsOne hundred and twenty patients underwent liver biopsy. Liver biopsy was not performed in one patient with cirrhosis due to ascites, and another patient was excluded because of an invalid biopsy specimen. Cirrhosis was observed in three patients (fibrosis stage F4 in two patients revealed by biopsy, and one patient with ascites confirmed by physical and Doppler ultrasound examination). Fibrosis stages F1 and F2 were present in 55 and 50 patients, respectively. The severity of liver inflammation was independently related to moderate to severe fibrosis (F ≥2). Older age and male sex showed an increasing tendency for more severe fibrosis (F3/F4) in the present cohort.ConclusionsBased on histopathology results, the progression of fibrosis in patients with CHC infected by repeated plasma donation is slow after HCV infection of approximately 20 years. Liver inflammation is closely related to the development of moderate to severe liver fibrosis